Methadone (DOLOPHINE®) is a synthetic opioid indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. It is a Schedule II substance under the United States Controlled Substances Act for its potential for abuse and risk of dependence.
Methadone is metabolized to a variety of inactive metabolites, including the primary metabolite 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP). EDDP is therefore a useful marker in identifying methadone.
The ARK™ EDDP Assay is an immunoassay intended for the qualitative and/or semiquantitative determination of EDDP in human urine at a cutoff concentration of 100 ng/mL and 300 ng/mL.
- The ARK™ EDDP Assay provides a simple and rapid analytical screening procedure for detecting EDDP
- Sensitive and specific for detection of EDDP in human urine
- Low cross-reactivity to Methadone– ensuring patients are taking their medication and there are no positive results due to urine spiking
- 0 – 1000 ng/mL calibration range; 100 ng/mL and 300 ng/mL cutoffs
ARK™ is a trademark of ARK Diagnostics, Inc.
Calibrator: ARK™ EDDP Calibrator
Control: ARK™ EDDP Control
Product Availability: USA
Sample Type: Urine
Contact us to get more information, become part of our distribution network, or ask a question about our products and their availability in your region:
|ARK™ EDDP Assay||5051-0001-00||R1 1 x 28mL, R2 1 x 14mL|
|ARK™ EDDP Assay||5051-0001-01||R1 1 x 115mL, R2 1 x 58mL|